Technical Comparison
TransCode Therapeutics, Inc. - Common Stock vs NVIDIA Corporation - Common Stock
Real-time financial comparison matrix between RNAZ and NVDA.
Primary Asset
RNA
TransCode Therapeutics, Inc. - Common Stock
Market Rank #1004203Live Price$1.63
Market Capitalization$28M
24h Change+0.00%
Circulating Supply17M RNAZ
Comparison Asset
NVD
NVIDIA Corporation - Common Stock
Market Rank #101Live Price$207.24
Market Capitalization$5T
24h Change+1.27%
Circulating Supply24B NVDA
Market Metric Matrix
| Comparison Metric | RNAZ Value | NVDA Value | Dominant Asset |
|---|---|---|---|
| Market Cap Rank | #1004203 | #101 | NVIDIA Corporation - Common Stock |
| Unit Price Valuation | $1.63 | $207.24 | NVIDIA Corporation - Common Stock |
| Total Liquid Cap | $28M | $5T | NVIDIA Corporation - Common Stock |
Frequently Asked Questions
Is TransCode Therapeutics, Inc. - Common Stock bigger than NVIDIA Corporation - Common Stock?
TransCode Therapeutics, Inc. - Common Stock has a market cap of $28M, while NVIDIA Corporation - Common Stock sits at $5T. Therefore, NVIDIA Corporation - Common Stock is currently the larger financial asset by market capitalization.
What is the price ratio between TransCode Therapeutics, Inc. - Common Stock and NVIDIA Corporation - Common Stock?
Currently, 1 RNAZ is worth 0.007865 NVDA.